AA
Abivax S.A.
AAVXF · OTC
$139.00 +0.00% (+$0.00)
Market Cap 9.10B €
P/E Ratio -
Div. Yield -
ROE 165.18%
Bulios Fair Price
$113.66
18.2% downside
Current Price
$139
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AAVXF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 20.00x
P/FCF N/A
P/FFO N/A
Growth
100 /100
Growing Book val. growth 522.98%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 57.52%
ROIC 48.36%
Debt
69 /100
Low Current ratio 8.75x
Int. coverage -8.79x
Debt/Equity 0.07x
Stability
26 /100
Unstable Profitable years 0
EPS volatility 46.54%
Beta -0.21x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AAVXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Marc de Garidel
Employees
69
Headquarters
Paris
Upcoming events
14 DEC
Earnings
Upcoming earnings report